COYA: Coya Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 87.30
Enterprise Value ($M) 48.96
Book Value ($M) 39.58
Book Value / Share 2.37
Price / Book 2.21
NCAV ($M) 39.54
NCAV / Share 2.36
Price / NCAV 2.21

Profitability (mra)
Return on Invested Capital (ROIC) -0.38
Return on Assets (ROA) -0.40
Return on Equity (ROE) -0.46

Liquidity (mrq)
Quick Ratio 11.59
Current Ratio 11.59

Balance Sheet (mrq) ($M)
Current Assets 44.31
Assets 44.35
Liabilities 4.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3.55
Operating Income -17.22
Net Income -14.88

Cash Flow Statement (mra) ($M)
Cash From Operations -10.29
Cash from Investing -0.03
Cash from Financing 16.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A DME Capital Management, LP 9.90
02-10 13G/A Hirschman Orin 8.00 14.56
11-12 13G/A Vanguard Group Inc 5.55 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 4,609 73,146 6.30
2025-04-16 13,486 54,860 24.58
2025-04-15 4,471 21,392 20.90
2025-04-14 11,372 79,802 14.25

(click for more detail)

Similar Companies
COCP – Cocrystal Pharma, Inc. COEP – Coeptis Therapeutics Holdings, Inc.
CORT – Corcept Therapeutics Incorporated CPRX – Catalyst Pharmaceuticals, Inc.
CRBP – Corbus Pharmaceuticals Holdings, Inc.


Financial data and stock pages provided by
Fintel.io